Scalable 3D organoid modeling for drug discovery

31 Oct 2025
Cameron Smith-Craig
Cameron Smith-Craig
Pharma and Applied Sciences Editor

Discover how to overcome the challenges of scaling 3D organoid models for high-throughput drug discovery. This comprehensive guide delivered in partnership with Molecular Devices explores innovative solutions for automating organoid culture, screening, and analysis.

Learn about:

  • Patient-derived 3D Ready™ Organoids and Expansion Services
  • The CellXpress.ai® Automated Cell Culture System
  • High-content imaging with ImageXpress® HCS.ai and IN Carta® software
  • AI-powered workflows for toxicity screening and phenotypic profiling

Ideal for researchers seeking reproducible, scalable, and human-relevant models to accelerate drug development and personalized medicine.

Links

Tags